All Type of News
Lee Kyung-ho likely to be nominated as KPMA head
Lee Kyung-ho, an incumbent president of Inje University, is likely to be new president of the Korea Pharmaceutical Manufacturers Association.
The association said it will appoint a new president at the special meet...
53 companies to spend 540 billion won in R&D this year
A total of 53 local drug makers are expected to invest 540 billion won in research and development this year, according to the Korea Drug Research Association.
According to KDRA data, these companies will spend 312...
Doctors raise doubts on DRG-based payment
The government needs to re-evaluate the feasibility of diagnosis-related group (DRG) payment as only eight percent of all medical institutions join the prospective payment system, according to a local medical professi...
KFDA nods ACT based wound healing therapy
The Korea Food and Drug Administration said it has approved a new autologous cell therapy (ACT) developed by S. Biomedics, a local biopharmaceutical company.
Autologous material can be utilized as both a stand-alon...
Test for pharmacy school hopefuls due on Sept. 23
The state-run pharmacy school admission test, Pharmacy Education Eligibility Test (PEET), will be held in five cities on August 23, the Commission for Korea Pharmacy Education announced on May 25.
PEET, one of the...
KFDA to set up OTC oriented department
The Korea Food and Drug Administration has unveiled a plan to establish a new department to deal with over-the-counter (OTC) drugs. Possibly within early next year.
According to the drug agency, the OTC department ...
1 out of 5 local clinical trials focus on anticancer drug
The number of domestic clinical trials undertaken in Korea was 1,485 for the last five years and among them, Korean firms sponsored 309 clinical trials for the development of new antineoplastic agents to treat gastric...
Combo pills perks up firms’ profit
Influenced by the recent announcement of the drug agency announcement that 507 combination drugs should be subject to bioequivalence testing from this October, a growing number of companies are rushing to produce comb...
Implementing global budget Payment scheme to reduce healthcare costs
One of the reasons for the government’s efforts to lower drug prices is the rapid increase in health care expenses and spending on drugs in Korea.
Due to the rapid population aging in Korea - Korea is predicted to...
Rewards for innovation is essential
The main reason why companies want the pharmaceutical market and the pricing and reimbursement system to be predictable and transparent is that pharmaceutical R&D investment is very long-term and carries a significant...
